News | January 13, 2012

Accuray Radiation Therapy Systems Surpasses 600 Installations Globally

January 13, 2012 — Accuray said this week there had been significant momentum in global adoption of its CyberKnife robotic radiosurgery system and TomoTherapy system. Along with the company's short and long-term growth strategy, this news was presented by Accuray President and CEO Euan Thomson, Ph.D., as part of the 30th Annual J.P. Morgan Healthcare Conference in San Francisco.

Accuray has taken its installed base from zero to over 600 commercially released systems in approximately a decade. That momentum has continued in the United States and internationally as a result of growing demand for effective and efficient radiation oncology treatments in emerging growth markets, and as the growing body of clinical evidence mounts supporting the advantages of image-guided radiosurgery and IMRT technologies.

As Accuray's earliest CyberKnife and TomoTherapy systems reach the end of their life cycle, new opportunities emerge for organic replacement business, along with the opportunity to capture the replacement market for older, pre-existing linacs at centers that desire newer, state-of-the-art capabilities. As the installed base grows, so too does Accuray's recurring revenue streams through service contracts, which together represent consistent annual growth.

By combining the two radiation oncology technologies focused on personalized patient care, Accuray has seen growing interest in both the TomoTherapy and CyberKnife technologies. The company's installations currently span 33 countries.

For more information: www.accuray.com

Related Content

ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.
 

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case
News | Treatment Planning | March 08, 2019
Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's...
Videos | Proton Therapy | March 01, 2019
ITN Associate Editor Jeff Zagoudis speaks with Mark Pankuch, Ph.D., director of physics and dosimetry at the...
Videos | Proton Therapy | February 28, 2019
ITN Associate Editor Jeff Zagoudis speaks with ...